أخبار

COVID-19: TIF Releases Position Statement on the Inclusion of Thalassaemia & SCD Patients in the High-Risk Population

COVID-19: TIF Releases Position Statement on the Inclusion of Thalassaemia & SCD Patients in the High-Risk Population

The SARS-CoV-2 infection presents particular challenges and great risks to patients with thalassaemia and sickle cell disease (SCD) and, if their appropriate clinical management as described in International Guidelines is…
TIF and EHA Explore How COVID-19 Is Affecting Thalassemia & SCD Patients

TIF and EHA Explore How COVID-19 Is Affecting Thalassemia & SCD Patients

On 16 April, TIF and the European Hematology Association (EHA) successfully organised a highly interactive webinar entitled ”Thalassaemia/SCD and COVID-19: Possible risks and a proposal for a patient pathway during…
NOW ONLINE: TIF’s latest Informational Guide on Developing Vaccinations & Therapeutic Drugs for COVID-19

NOW ONLINE: TIF’s latest Informational Guide on Developing Vaccinations & Therapeutic Drugs for COVID-19

TIF has made an effort to put together a list of studies/clinical trials for treatments and vaccines about COVID-19, which is by no means exhaustive as this situation is ever-changing…
“Now I Am The Voice“: A journey of self‐discovery through the eyes of a Thalassaemic

“Now I Am The Voice“: A journey of self‐discovery through the eyes of a Thalassaemic

TIF’s Expert Patient and long-standing collaborator and friend, Maria Hadjidemetriou, shares her inspiring and thought-provoking journey with thalassaemia and reflects on the lessons it has taught her. Click on the…
JUST LANDED: A new TIF Publication on Blood & COVID-19

JUST LANDED: A new TIF Publication on Blood & COVID-19

Is the new coronavirus transfusion transmittable? What is the guidance that internationally acclaimed bodies, such as the World Health Organisation (WHO), the US Centers for Disease Control and Prevention (CDC)…
Revisiting WHO Guidance Document on the Protection of Blood Supplies developed with TIF’s contribution

Revisiting WHO Guidance Document on the Protection of Blood Supplies developed with TIF’s contribution

  In an effort to assist national blood services in the development of plans to respond to any emerging infectious threats, as far as the sufficiency or safety of the…
Novavax to start human trial for ‘ideal’ coronavirus vaccine candidate

Novavax to start human trial for ‘ideal’ coronavirus vaccine candidate

The biotech company Novavax announced today that it has identified an “ideal” coronavirus vaccine candidate — and is set to launch the first clinical human trial in mid-May. The candidate,…
WORLD HEALTH DAY: Honouring the work of nurses and midwives – 7 April 2020

WORLD HEALTH DAY: Honouring the work of nurses and midwives – 7 April 2020

Nurses and other health workers are at the frontlines of COVID-19 response, putting their own health at risk to protect the broader community. This World Health Day, the World Health Organisation…
IMPORTANT ANNOUNCEMENT: TIF reschedules the International Thalassaemia Day 2020 Celebrations for the 8th of September due to coronavirus

IMPORTANT ANNOUNCEMENT: TIF reschedules the International Thalassaemia Day 2020 Celebrations for the 8th of September due to coronavirus

  Given the unprecedented global public health crisis brought on by the COVID-19 pandemic, TIF announces that the celebrations of the International Thalassaemia Day 2020 on the 8th of May, including…
TIF publishes new material on the COVID-10 Pandemic

TIF publishes new material on the COVID-10 Pandemic

TIF continues the efforts to address the questions and concerns of its global patients’ and healthcare professionals’ community about the COVID-19 Pandemic and, in doing so, it has issued 2…
زر الذهاب إلى الأعلى